Medical Industry Technology Serving Manitoba

Our mission: Make smallholders dairy farmers more profitable , traceable and sustainable - one feature at a time ...

Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein DiscoveryTM. Through our technology, we accelerate breakthrough improvements in human health and empower life science ...

Founded in 1947 by Dr. Ing. Arturo Gilardoni, the company has established itself as a pioneer in the development and innovation of X-ray technology. Initially focused on X-ray tubes, Gilardoni has broadened its scope to include a range of advanced ...

Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...

Henry Schein Hub is a comprehensive provider of solutions tailored to the healthcare sector, enabling over 7,000 healthcare providers to optimize their clinical, financial, and operational functions. The platform offers an array of peer-reviewed ...

We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...

We recycle CO₂ for sustainable protein production. We offer sustainably produced proteins that are processed into specific end products through various downstream processes. Our high-tech bio-process uses carbon dioxide as a source to produce ...

Premas Life Sciences (PLS) is a young, dynamic, and focused organization introducing game-changing niche technologies in Genomics, Cell Biology, and Biopharma to boost innovative research and diagnostics in India. We are also the knowledge partners ...

Nowadays, medical technology has to try to keep up with medical research and respond to the increased demands of both doctors and patients. The rapidly developing field of sleep medicine in particular requires innovative solutions. Coming from the ...

RaySearch® is advancing cancer treatment through pioneering software. Software has unlimited potential, and it is now the driving force for innovation in oncology. Medical science never stands still and neither does RaySearch. We work in close ...

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. The recently introduced Sculptura robotic ...

BL Dynamics Inc. offers various lines of products producing ultrafine bubbles. Bubbles smaller than 50µm in diameter have unique properties which are different from larger bubbles. We have delivered our system, Nano-BL special aeration, to many ...

Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...

For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of ...

Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine. Hemagen's mission is to offer high quality diagnostic test kits in user friendly formats. We continue to the highest quality gold standard test ...

Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...

We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...

Tellgen Corporation was established in 2003 at the Medicine Valley in Shanghai, also known as the Silicon Valley of China, which is the first to develop reagents based on Luminex Platforms. Went public in 2017 in Shenzhen and grew to 1000 employees. ...

Tryton Medical is a leading developer of novel stent systems for the treatment of bifurcation lesions. The co-founders of the company, Aaron V. Kaplan M.D. and H. Richard Davis, recognized an unmet need in coronary artery disease treatment. ...

Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...